C3 nephritic factors: A changing landscape.
Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, Pa; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa. Electronic address: levy.erez.daniella@gmail.com.
Daniella
D
Levy Erez
Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, Pa; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
Kevin E
KE
Meyers
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Kathleen E
KE
Sullivan
D001323:Autoantibodies / Q000276:immunology*; D003178:Complement C3 Nephritic Factor / Q000276:immunology* / Q000378:metabolism; D003170:Complement Pathway, Alternative / Q000276:immunology*; D004198:Disease Susceptibility / Q000276:immunology*; D015433:Glomerulonephritis, Membranous / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism; D006801:Humans; D052496:Lipodystrophy, Familial Partial / Q000209:etiology / Q000378:metabolism / Q000473:pathology
D001323:Autoantibodies; D003178:Complement C3 Nephritic Factor
C3 glomerulopathy; C3 nephritic factor; alternative complement activation; dense-deposit disease; eculizumab; membranoproliferative glomerulonephritis; partial lipodystrophy